Vaccines Developer Visterra Postpones $50M IPO
Venture-backed vaccines maker Visterra, which was about to price an estimated $50 million initial public offering, reportedly postponed plans Thursday because of market conditions, becoming the third issuer to do so...To view the full article, register now.
Already a subscriber? Click here to view full article